Gwrthrychau elusennol
THE OBJECTS FOR WHICH THE COMPANY IS ESTABLISHED ARE TO PROTECT, PRESERVE AND ADVANCE ALL OR ANY ASPECTS OF THE HEALTH AND WELFARE OF HUMAN BEINGS AND TO ADVANCE AND PROMOTE KNOWLEDGE AND EDUCATION BY ENGAGING IN, ENCOURAGING AND SUPPORTING: 1) INVESTIGATIONS INTO THE SEPARATE AND COMBINED EFFECTS OF GENETIC, ENVIRONMENTAL (INCLUDING LIFESTYLE, PHYSIOLOGICAL AND ENVIRONMENTAL EXPOSURES) AND OTHER FACTORS ON HUMAN HEALTH AND WELFARE AND ON THE RISK AND CAUSATION OF DISEASES IN THE HUMAN POPULATION; (2) THE ESTABLISHMENT, HOLDING, OPERATION, MANAGEMENT, PROMOTION, SUPPORT, EXPANSION, IMPROVEMENT AND SAFEGUARDING OF A COLLECTION OF BIOMEDICAL, BIOCHEMICAL, EPIDEMIOLOGICAL, GENETIC AND OTHER DATA AND BLOOD AND OTHER BIOLOGICAL AND BIOCHEMICAL SAMPLES OBTAINED AND DEVELOPED THROUGH, FOR THE PURPOSE OF AND/OR IN CONNECTION WITH SOME OR ALL OF THE INVESTIGATIONS REFERRED TO IN PARAGRAPH (1) AND PERTAINING TO A COHORT OF HUMAN PARTICIPANTS
("DATA AND SAMPLES"), FOR USE IN A RESEARCH, KNOWLEDGE AND INFORMATION RESOURCE PROVISIONALLY KNOWN AS THE UK BIOBANK ("THE RESOURCE");
(3) RESEARCH INTO BIOLOGICAL AND MEDICAL SCIENCES AND OTHER DISCIPLINES WHICH MAY CONTRIBUTE TO THE IMPROVEMENT OF HUMAN HEALTH AND WELFARE
("THE BIOSCIENCES"); (4) THE DISCOVERY, INVENTION, IMPROVEMENT, DEVELOPMENT AND APPLICATION OF TREATMENTS, CURES, DIAGNOSTICS AND OTHER MEDICINAL AGENTS, METHODS AND PROCESSES THAT MAY IN ANY WAY RELIEVE ILLNESS, DISEASE, DISABILITY OR DISORDERS OF WHATEVER NATURE IN HUMAN BEINGS; AND
(5) THE STUDY AND UNDERSTANDING OF ANY OF THE BIOSCIENCES.
